Surgical Management of Carcinoma of the Prostate

McNeal JE. The prostate gland: morphology and pathobiology. Mono Urol 1983; 4:3–35.Google Scholar

Walsh PC, Lepor H, Eggleston JC. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983;4:473–485.CrossRefPubMedGoogle Scholar

Schlegel PN, Walsh PC. Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function. J Urol 1987;138:1402–1406.PubMedGoogle Scholar

Brooks JD. Anatomy of the lower urinary tract and male genitalia. In: Walsh PC, Retik AB, Vaughan, Jr ED, Wein AJ, eds. Campbell’s Urology. Philadelphia: WB Saunders, 2002:41–80.Google Scholar

Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into aetiology and prevention. J Urol 1982;128:492–497.PubMedGoogle Scholar

Myers RP, Goellner JR, Cahill DR. Prostate shape, external striated urethral sphincter and radical prostatectomy: the apical dissection. J Urol 1987;138:543–550.PubMedGoogle Scholar

Remzi M, Waldert M, Djavan B. Preoperative nomograms and artificial neural networks (ANNs) for identification of surgical candidates. Eur Urol EAU Update Series 2005;3:63–71.CrossRefGoogle Scholar

Bostwick DG, Grignon D, Hammond EH, et al. Predictive factors in prostate cancer. College of Pathologists consensus statements 1999. Arch Pathol Lab Med 2000; 124: 996–1000.Google Scholar

Oestrling JE, Brendler CB, Epstein JI, et al. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized Adenocarcinoma of the prostate. J Urol 1987; 138:92–98.Google Scholar

Babaian RJ, Grunow WA. Reliability of Gleason grading system in comparing prostate biopsies with total prostatectomy specimens. Urology 1985;25:564–567.CrossRefPubMedGoogle Scholar

Steinberg D, Sauvageot J, Epstein JI. Correlation of prostate needle biopsy and radical prostatectomy: Gleason grade in academic and community settings. Mol Pathol 1996; 9:83A.Google Scholar

Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997;277:1445–1451.CrossRefPubMedGoogle Scholar

Freedland SJ, Aronson WJ, Terris MK, et al. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. J Urol 2003; 169:2136–2141.CrossRefPubMedGoogle Scholar

Nelson BA, Shappell SB, Chang SS, et al. Tumour volume is an independent predictor of prostate specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. BJU Int 2006;97:1169–1172.CrossRefPubMedGoogle Scholar

Cheng L, Zincke H, Blute ML, Bergstrahl EJ, et al. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 2001;91:66–73.CrossRefPubMedGoogle Scholar

Daneshmand S, Quek ML, Stein JP, Lieskovsky G, et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 2004;172:2252–2255.CrossRefPubMedGoogle Scholar

Aus G, Abbou CC, Pacik D, et al. EAU working group on Oncological urology. EAU guidelines on prostate cancer. Eur Urol 2001;40:97–101.CrossRefPubMedGoogle Scholar

Stephenson AJ, Kattan MW. Nomograms for prostate cancer. BJU Int 2006;98:39–46.CrossRefPubMedGoogle Scholar

Ross PL, Scardino PT, Kattan MW, et al. A catalogue of prostate cancer nomograms. J Urol 2001;165:1562–1568.CrossRefPubMedGoogle Scholar

Partin AW, Mangold LA, Lamm DM, et al. Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology 2001;58(6): 843–848.CrossRefPubMedGoogle Scholar

Blute ML, Bergstralh EJ, Partin AW, et al. Validation of Partin tables for predict ing pathological stage of clinically localized prostate cancer. J Urol 2000;164(5): 1591–1595.CrossRefPubMedGoogle Scholar

Graefen M, Augustin H, Karakiewicz PI, et al. Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables. Eur Urol 2003;43(1):6–10; discussion 11.CrossRefPubMedGoogle Scholar

Kattan MW, Eastham JA, Stapleton AMF, Wheeler TM, Scardino PT. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998;90(10):766–771.CrossRefPubMedGoogle Scholar

Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999; 17: 499–507.Google Scholar

Stephenson AJ, Scardino PT, Eastham JA, et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 2006 7;98(10):715–717.PubMedCrossRefGoogle Scholar

Remzi M, Djavan B. Artificial neural networks in Urology 2004. Eur Urol 2004;suppl 3:33–38.Google Scholar

Narayan P, Fournier G, Gajendran V, et al. Utility of preoperative prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer. Urology 1994;44:519–524.CrossRefPubMedGoogle Scholar

Alagiri M, Colton MD, Seidmon EJ, et al. The staging lymphadenectomy: implications as an adjunctive procedure for clinically localized prostate cancer. Br J Urol 1997; 80:243–246.PubMedGoogle Scholar

Petros JA, Catalona WJ. Incidence of unsuspected lymph node metastasis in 521 consecutive patients with clinically localized prostate cancer. J Urol 1992; 147: 1574–1575.PubMedGoogle Scholar

Danella JF, DeKernion JB, Smith RB, Steckel J. The contemporary incidence of lymph node metastases in prostate cancer. Implications for laparoscopic lymph node dissection. J Urol 1993;149:1488–1491.PubMedGoogle Scholar

Smith JA Jr, Seaman JP, Gleidman JB, Middleton RG. Pelvic lymph node metastases from prostatic cancer. Influence of tumor grade and stage in 452 consecutive patients. J Urol 1983;130(2):290–292.PubMedGoogle Scholar

Barth PJ, Gerharz EW, Ramaswamy A, Riedmiller H. The influence of lymph node counts on the detection of pelvic lymph node metastasis in prostate cancer. Pathol Res Pract 1999;195:633–636.PubMedGoogle Scholar

Weckermann D, Goppelt M, Dorn R, et al. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of ≥10ng/mL and biopsy Gleason score ≤6, and their influence on PSA progression-free survival after radical prostatectomy. BJU Int 2006;97:1173–1178.CrossRefPubMedGoogle Scholar

Masterson TA, Bianco FJ Jr, Vickers AJ, et al. The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. J Urol 2006;175(4):1320–1324; discussion 1324–1325.CrossRefPubMedGoogle Scholar

Cagiannos I, Karakiewicz P, Eastham JA, et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 2003;170:1798–1803.CrossRefPubMedGoogle Scholar

Hoenig DM, Chi S, Porter C, et al. Risk of nodal metastasis at laparoscopic pelvic lymphadenectomy using PSA, Gleason score and clinical stage in men with localized prostate cancer. J Endourol 1997;11:263–265.CrossRefPubMedGoogle Scholar

DiMarco DS, Zincke H, Sebo TJ, et al. The extent of lymphadenectomy for pTxNo prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol 2005;173:1121–1125.CrossRefPubMedGoogle Scholar

Schumacher MC, Burkhard FC, Thalmann GN, et al. Is pelvic lymph node dissection necessary in patients with serum PSA <10ng/ml undergoing radical prostatectomy for prostate cancer? Eur Urol 2006;50:272–279.CrossRefPubMedGoogle Scholar

Bollens R, Roumeguere T, Vanden Bossche M, et al. Comparison of laparoscopic radical prostatectomy techniques. Curr Urol Rep 2002;3(2):148–151.CrossRefPubMedGoogle Scholar

Lepor H, Nieder AM, Ferrandino MN. Intraoperative and postoperative complications of radical retropubic prostatectomy ina consecutive series of 1,000 cases. J Urol 2001;166:1729–1733.CrossRefPubMedGoogle Scholar

Augustin H, Hammerer P, Graefen M, et al. Intraoperative and perioperative morbidity of contemporary radical retropubic prostatectomy in a consecutive series of 1243 patients: results of a single center between 1999 and 2002. Eur Urol 2003;43: 113–118.CrossRefPubMedGoogle Scholar

Katz R, Borkowski T, Hoznek A, et al. Operative management of rectal injuries during laparoscopic radical prostatectomy. Urology 2003;62(2):310–313.CrossRefPubMedGoogle Scholar

Nyam DC, Pemberton JH. Management of iatrogenic rectourethral fistula. Dis Colon Rectum 1999;42(8):994–997; discussion 997–999.CrossRefPubMedGoogle Scholar

Moinzadeh A, Abouassaly R, Gill IS, Libertino JA. Continuous needle vented Foley catheter suction for urinary leak after radical prostatectomy. J Urol 2004;171(6pt 1):2366–2367.CrossRefPubMedGoogle Scholar

Davidson PJ, van den Ouden D, Schroeder FH. Radical prostatectomy. Prospective assessment of mortality and morbidity. Eur Urol 1996;29:168–173.PubMedGoogle Scholar

Surya BV, Provet J, Johanson K-E, Brown J. Anastomotic strictures following radical prostatectomy: risk factors and management. J Urol 1990;143:755–758.PubMedGoogle Scholar

Siegel T, Moul J, Speval M, et al. The development of erectile dysfunction in men treated for prostate cancer. J Urol 2001;165:430–435.CrossRefPubMedGoogle Scholar

Moreland RB. Is there hypoxia in penile fibrosis? A viewpoint presented to the society for the study of impotence. Int J Impot Res 1998;10:113–120.CrossRefPubMedGoogle Scholar

User HM, Hairston JH, Zelner DJ, et al. Penile weight and cell subtype changes ina postradical prostatectomy model of erectile dysfunction. J Urol 2003; 169: 1175–1179.CrossRefPubMedGoogle Scholar

Montorosi F, Guazzoni G, Strambi LF, et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with or without early intracavernosus injections of alprostadil results of a prospective randomized trial. J Urol 1997;158:1408–1410.CrossRefGoogle Scholar

Peyromaure M, Ravery V, Boccon-Gibod L. The management of stress urinary incontinence after radical prostatectomy. BJU Int 2002;90:155–161.CrossRefPubMedGoogle Scholar

Chao R, Mayo M E. Incontinence after radical prostatectomy: detrusor or sphincter causes. J Urol 1995; 154:16–18.CrossRefPubMedGoogle Scholar

Franke JJ, Barrit Gilbert W, Grier J, et al. early post-prostatectomy pelvic floor biofeedback. J Urol 2000;163:191–193.CrossRefPubMedGoogle Scholar

Cummings JM, Boullier JA, Parra RO. Transurethral collagen injections in the therapy of post-radical prostatectomy stress incontinence. J Urol 1996;155:1011–1013.CrossRefPubMedGoogle Scholar

Fleshner N, Herschorn S. The artificial urinary sphincter for post-radical prostatectomy incontinence. Impact on urinary symptoms and quality of life. J Urol 1996;155: 1260–1264.CrossRefPubMedGoogle Scholar

Klijn AJ, Hop WCJ, Mickisch G, et al. The artificial urinary sphincter in men incontinent after radical prostatectomy: 5-year actuarial adequate function rates. Br J Urol 1998;82:530–533.PubMedGoogle Scholar

Vaidya A, Soloway MS. Salvage radical prostatectomy for radiorecurrent prostate cancer revisited. J Urol 2000;164:1998–2001.CrossRefPubMedGoogle Scholar

Seitz C, Remzi M, Djavan B. Immediate treatment after PSA progression. Eur Urol Suppl 2005;4:28–42.CrossRefGoogle Scholar

Rogers E, Ohori M, Kassabian VS, et al. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol 1995;153:104–110.CrossRefPubMedGoogle Scholar

Zigeuner R, Schips L, Lipsky K, et al. Detection of prostate cancer by TURP or open surgery in patients with previously transrectal prostate biopsies. Urology 2003;62: 883–887.CrossRefPubMedGoogle Scholar

Flam TA, Peyromaure M, Chauveinc L, et al. Post-brachytherapy transurethral resection of the prostate in patients with localized prostate cancer. J Urol 2004;172: 108–111.CrossRefPubMedGoogle Scholar